Development of a treatment for the durable remission of HIV using autologous human CAR T cells that target B cell follicles
|Effective start/end date
|6/18/20 → 5/31/21
- MARPAM PHARMA LLC
- NATIONAL INSTITUTES OF HEALTH (NIH)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.